---
schema_version: "secwatch.filing_event.v1"
accession: "0000832101-22-000002"
form_type: "8-K"
ticker: "IEX"
cik: "0000832101"
company_name: "IDEX CORP /DE/"
filed_at: "2022-02-02T23:59:59+00:00"
generated_at: "2026-06-27T12:39:20.488703+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# IDEX reports record Q4 EPS $1.55, full-year EPS $5.88; acquires Nexsight for $120M; guides FY22 adj EPS $7.33-$7.63

## Summary
- Record Q4 EPS $1.55 on sales $714.8M (+16% overall, +11% organic vs Q4 2020); full year EPS $5.88 (+19%).
- Full year sales $2.8B (+18%); adjusted EPS $6.30 (+21%); record Q4 orders $795.3M (+17%).
- Acquired Nexsight (Envirosight, WinCan, MyTana, Pipeline Renewal Technologies) for $120M cash; expected close Q1 2022.
- FY22 guidance: organic sales growth 5-8%; GAAP EPS $6.70-$7.00, adjusted EPS $7.33-$7.63 under revised definition.
- Health & Science Technologies led with Q4 sales +25% (+16% organic); segment margin up 210 bps to 25.8%.

## SEC filing metadata
- accession: 0000832101-22-000002
- form_type: 8-K
- ticker: IEX
- cik: 0000832101
- company_name: IDEX CORP /DE/
- filed_at: 2022-02-02T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/832101/000083210122000002/0000832101-22-000002-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/832101/000083210122000002/iex-20220201.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000832101-22-000002
- JSON: https://secwatch.observer/filing/0000832101-22-000002.json
- Plain text: https://secwatch.observer/filing/0000832101-22-000002.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.